4//SEC Filing
Gaenzle Christopher L 4
Accession 0001104659-21-083613
CIK 0001613859other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:28 PM ET
Size
21.8 KB
Accession
0001104659-21-083613
Insider Transaction Report
Form 4
Gaenzle Christopher L
EVP, Chief Admin Officer & GC
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−4,326→ 17,114 totalExercise: $103.30Exp: 2030-06-01→ Common Stock (4,326 underlying) - Sale
Common Stock
2021-06-17$169.75/sh−692$117,467→ 34,500 total - Exercise/Conversion
Common Stock
2021-06-17$101.42/sh+18,958$1,922,720→ 57,671 total - Exercise/Conversion
Common Stock
2021-06-17$95.94/sh+4,213$404,195→ 38,713 total - Exercise/Conversion
Common Stock
2021-06-17$103.30/sh+4,326$446,876→ 61,997 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−18,958→ 37,500 totalExercise: $101.42Exp: 2028-08-10→ Common Stock (18,958 underlying) - Sale
Common Stock
2021-06-17$167.40/sh−1,300$217,620→ 60,697 total - Sale
Common Stock
2021-06-17$168.06/sh−13,391$2,250,491→ 47,306 total - Sale
Common Stock
2021-06-17$169.41/sh−12,114$2,052,233→ 35,192 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-06-17−4,213→ 16,666 totalExercise: $95.94Exp: 2029-08-13→ Common Stock (4,213 underlying)
Footnotes (8)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $166.72 to $167.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (3), (4) and (5) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $167.72 to $168.67, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $168.73 to $169.70, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $169.73 to $169.79, inclusive.
- [F6]The option vests in three equal annual installments of 8,334 beginning on August 13, 2020.
- [F7]The option vests in four equal annual installments of 18,750 beginning on August 10, 2019.
- [F8]The option vests in three equal annual installments of 8,556 beginning on June 1, 2021.
Documents
Issuer
PRA Health Sciences, Inc.
CIK 0001613859
Entity typeother
Related Parties
1- filerCIK 0001624044
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:28 PM ET
- Size
- 21.8 KB